- Home
- ABL vs PAHC Comparison
ABL vs PAHC Comparison
Compare ABL & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABL
- PAHC
- Stock Information
- Founded
- ABL 2004
- PAHC 1946
- Country
- ABL United States
- PAHC United States
- Employees
- ABL N/A
- PAHC N/A
- Industry
- ABL Investment Managers
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- ABL Finance
- PAHC Health Care
- Exchange
- ABL Nasdaq
- PAHC Nasdaq
- Market Cap
- ABL 757.0M
- PAHC 682.5M
- IPO Year
- ABL N/A
- PAHC 2014
- Fundamental
- Price
- ABL $8.78
- PAHC $23.47
- Analyst Decision
- ABL Strong Buy
- PAHC Sell
- Analyst Count
- ABL 4
- PAHC 3
- Target Price
- ABL $14.13
- PAHC $19.00
- AVG Volume (30 Days)
- ABL 44.3K
- PAHC 182.4K
- Earning Date
- ABL 11-07-2024
- PAHC 11-06-2024
- Dividend Yield
- ABL N/A
- PAHC 2.06%
- EPS Growth
- ABL N/A
- PAHC N/A
- EPS
- ABL N/A
- PAHC 0.43
- Revenue
- ABL $102,407,324.00
- PAHC $1,046,762,000.00
- Revenue This Year
- ABL $67.69
- PAHC $21.75
- Revenue Next Year
- ABL $61.70
- PAHC $12.67
- P/E Ratio
- ABL N/A
- PAHC $54.34
- Revenue Growth
- ABL 77.68
- PAHC 7.17
- 52 Week Low
- ABL $6.53
- PAHC $9.49
- 52 Week High
- ABL $13.25
- PAHC $25.98
- Technical
- Relative Strength Index (RSI)
- ABL 49.67
- PAHC 50.44
- Support Level
- ABL $8.12
- PAHC $23.09
- Resistance Level
- ABL $9.21
- PAHC $25.98
- Average True Range (ATR)
- ABL 0.46
- PAHC 0.99
- MACD
- ABL 0.06
- PAHC -0.13
- Stochastic Oscillator
- ABL 64.60
- PAHC 41.10
About ABL Abacus Life Inc.
Abacus Life Inc is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.